Diabetes Drugs Won the Weight-Loss Battle, Reshaping Weight Care: Research centers keep long waitlists to assess long-term effects,
The new diabetes-drug class used for weight loss became one of the most prescribed worldwide, opening a twin health-and-economy file. Supply shortages and high costs raised equality questions between rich and poor countries.
The new diabetes-drug class used for weight loss became one of the most prescribed worldwide, opening a twin health-and-economy file.
Supply shortages and high costs raised equality questions between rich and poor countries.
Growing research documents effects beyond lost kilos, including heart-risk and inflammation improvements.
Research centers keep long waitlists to assess long-term effects, a story unfolding dose by dose.
Join the room to follow the new exclusives as they drop.
Enter the RoomComments(0)
More Stories
All News
Exclusive: New International City-Science Consortium Studies Autonomous Transit in Capital Cores: Urban transport’s future is drawn in academic archives before
The Fed Starts Easing Interest Rates and Global Markets Shift Gears: The new cycle touches everything from bonds to currencies,
A New Telescope Captures a Signal Billions of Years Old From an Ever-Expanding Cosmos